Results 31 to 40 of about 1,635,931 (154)

Suicidality and Suicide Attempt in a Young Female on Long-Term Sertraline Treatment

Indian Journal of Psychological Medicine, 2012
A 22-year-old woman who was on sertraline 50 mg oral tablets once daily for 2 years for treatment of major depression took 30 such tablets (1500 mg) in a fit of rage, with a suicidal intent.
Ranjita Santra, Patralekha Ray Chaudhuri, Dibyendu Dhali, Shirsendu Mondal   +3 more
doaj   +1 more source

Pencarian Hubungan Adverse Event pada Obat Penenang dengan Apriori

Jurnal CoreIT: Jurnal Hasil Penelitian Ilmu Komputer dan Teknologi Informasi, 2016
SSRI (Selective Serotonin Reuptake Inhibitor) merupakan salah satu jenis obat antidepresan yang dikonsumsi penderita gangguan kecemasan dan gangguan panik dan juga paling banyak digunakan diseluruh dunia, karena diyakini mengurangi resiko bunuh diri ...
Meilinda Heriza, Muhammad Fikri, Lestari Handayani   +2 more
doaj   +1 more source

Chirality of Modern Antidepressants: An Overview [PDF]

Advanced Pharmaceutical Bulletin, 2017
The majority of modern antidepressants (selective serotonin reuptake inhibitors and selective serotonin and norepinephrine reuptake inhibitors) have one or two centers of asymmetry in their structure; resulting in the formation of enantiomers which may ...
Monica Budău, Gabriel Hancu, Aura Rusu, Melania Cârcu-Dobrin, Daniela Lucia Muntean   +4 more
doaj   +1 more source

A Novel Biotinylated Homotryptamine Derivative for Quantum Dot Imaging of Serotonin Transporter in Live Cells

Frontiers in Cellular Neuroscience, 2021
The serotonin transporter (SERT) is the primary target for selective serotonin reuptake inhibitor (SSRI) antidepressants that are thought to exert their therapeutic effects by increasing the synaptic concentration of serotonin.
Ian D. Tomlinson, Oleg Kovtun, Ruben Torres, Ruben Torres, Laurel G. Bellocchio, Travis Josephs, Sandra J. Rosenthal, Sandra J. Rosenthal, Sandra J. Rosenthal, Sandra J. Rosenthal, Sandra J. Rosenthal, Sandra J. Rosenthal   +11 more
doaj   +1 more source

Early-life exposure to selective serotonin reuptake inhibitors: Long-term effects on pain and affective comorbidities

, 2022
A growing body of evidence indicates that early-life exposure to selective serotonin reuptake inhibitor has long-term consequences on the offspring's pain in addition to affective disorders like anxiety disorder and major depression.
Joosten, E.A., Daniel L. A. van den Hove, de Kort, Anne R., Baudat, M., Elbert A. Joosten, van den Hove, D.L.A., Mathilde Baudat, Joosten, Elbert A., de Kort, A.R., van den Hove, Daniel L. A., Baudat, Mathilde, Anne R. de Kort   +11 more
core   +1 more source

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder

, 2015
Objective: The aim of this analysis was to assess the safety profile of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor (SSRI) antidepressants. Methods: A pooled analysis was conducted on data obtained from the integrated
Jonna Ahl, Celine Goldberger, JonDavid Sparks, Peng Liu, James M Martinez, Tina M Oakes, Mark Bangs, Mary Anne Dellva, Qi Zhang, Margaret B Ferguson, Beth A Pangallo   +10 more
core   +1 more source

Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects [PDF]

, 2004
Reboxetine is a selective noradrenaline reuptake inhibitor, whereas mirtazapine acts as an antagonist at noradrenergic alpha(2), serotonin (5-HT2), 5-HT3 and histamine H-1 receptors.
Baghai, Thomas C., Laakmann, G., Schule, C.   +2 more
core   +1 more source

Rivaroxaban and selective serotonin reuptake inhibitors: Bleeding risk resulting from their concomitant use

, 2022
20.500.12530/87912Objective: The combination of selective serotonin reuptake inhibitors with rivaroxaban may result in a dual interaction (pharmacokinetic and pharmacodynamic) depending on the type of selective serotonin reuptake inhibitor employed ...
Rosas-Espinoza, Cristian, Canales-Siguero, Dolores, Antonio Hernandez-Ramos, Jose, Miguel Ferrari-Piquero, Jose, Angel Bruni-Montero, Miguel, Manuel Caro-Teller, Jose   +5 more
core   +1 more source

Effect of glibenclamide on antinociceptive effects of antidepressants of different classes

Clinics, 2011
OBJECTIVES: The purpose of this work was to determine whether the intraperitoneal administration of glibenclamide as a K ATP channel blocker could have an effect on the antinociceptive effects of antidepressants with different mechanisms of action ...
Valiollah Hajhashemi, Bahareh Amin
doaj   +1 more source

Reversible Hemifacial Spasm after Starting Escitalopram

Case Reports in Neurology, 2020
This is a case of a patient who developed hemifacial spasm after he was started on escitalopram. His symptoms got worse after the dose was increased. The spasm resolved after the medication was stopped gradually.
Mazen Abdulrahaman Basheikh
doaj   +1 more source